Advanced Clinical Announces New Executive Vice President
News Apr 22, 2013
Advanced Clinical has announced an addition to its leadership team: Julie A. Ross, has been hired as Executive Vice President, CRO Operations.
Julie Ross is a tenured executive leader who has been instrumental in the development and the success of multiple clinical operations divisions.
Previously with inVentiv Health Clinical (formerly Pharmanet/i3), Ms. Ross served as Senior Vice President, Global Strategic Services and had oversight of Feasibility, Patient Recruitment and Retention, Global Study Start-up, Document Management and Publishing, Expedited Safety Reporting, Grants and Contracts, Clinical Trial Supply Management and Medical Writing.
Prior to her role at inVentiv, Ms. Ross led Essential Group, a full-service CRO and patient recruitment company, which she helped build and position for its acquisition by inVentiv Health.
“We are very excited to welcome Julie to the Advanced Clinical team,” said Leo Sheridan, CEO of Advanced Clinical. “We are honored to bring Julie’s caliber and experience to our team as we continue expanding our CRO solutions. Her diverse knowledge and expertise in clinical research, as well as her strong leadership skills, are a perfect fit for Advanced Clinical.”
A graduate of the University of Wisconsin, La Crosse with a bachelor's degree in Nuclear Medicine Technology, Ms. Ross has been in the clinical research industry for over twenty five years.
She has authored many clinical research articles and is a well-known industry speaker. Ms. Ross will be based out of Advanced Clinical’s headquarters in Deerfield, IL.
SYGNIS AG Announces Completion of Relocation of its Innova Biosciences UnitNews
Move forms part of integration into SYGNIS Group.READ MORE
Biomarker for Glioblastoma Predicts Clinical Course and Sensitivity to TreatmentNews
Scientists validate a biomarker indicative of patients with Glioblastoma prognosis and likely response to specific therapies.READ MORE
BC Platforms Announces Collaborations in Multiple Sclerosis ResearchNews
Company's technology and research platforms used to better understand genetic basis of MS.READ MORE
Comments | 0 ADD COMMENT
Annual Conference on Antimicrobials and Drug Resistance
Sep 24 - Sep 25, 2018
1st Alpine Winter Conference on Medicinal and Synthetic Chemistry
Jan 28 - Feb 01, 2018